To ensure precision and specificity of ligand -receptor induced signaling, co-receptors and modulatory factors play important roles. The membrane bound ligand Nogo-A induces inhibition of neurite outgrowth, cell spreading, adhesion and migration via multi-subunit receptor complexes. Here, we identified the 4-transmembrane-spanning protein tetraspanin-3 (TSPAN3) as a new modulatory co-receptor for the Nogo-A inhibitory domain Nogo-A-∆20.
Introduction
Growth inhibitory proteins restrict neurite outgrowth in the adult central nervous system (Giger et al., 2010; Schwab and Strittmatter, 2014; Yiu and He, 2006) . Among those, the transmembrane protein Nogo-A, which is enriched in CNS myelin (Caroni and Schwab, 1988; Chen et al., 2000) , is one of the most potent known inhibitors limiting regeneration and plasticity after injury (Cafferty and Strittmatter, 2006; Schwab, 2010; Schwab and Strittmatter, 2014; Wahl et al., 2014) . Nogo-A restricts neurite outgrowth via two different domains: Nogo-66 (rat aa1026-1091 ) and Nogo-A-∆20 (rat aa544-725; part of 'AminoNogo') (Chen et al., 2000; GrandPre et al., 2000; Oertle et al., 2003; Schwab, 2010) . In vivo, full-length Nogo-A might undergo transcytosis or proteolytic cleavage, resulting in the release of active fragments such as Nogo-A-Δ20 (Joset et al., 2010; Kempf et al., 2014; Thiede-Stan & Schwab, 2015) . In the developing CNS, Nogo-A-∆20 promotes migration of neuronal precursors, but inhibits primary brain microvascular endothelial cell migration, as well as the spreading of endothelial cells and fibroblasts (Kempf et al., 2014; Mathis et al., 2010; Oertle et al., 2003; Rolando et al., 2012; Schmandke et al., 2013; Walchli et al., 2013) . Although Nogo-A-∆20 and Nogo-66 signal via different receptors, the activation of RhoA is a common intracellular signal step downstream of both inhibitory domains (Joset et al., 2010; Kempf et al., 2014; Montani et al., 2009; Nash et al., 2009 ). While Nogo-66 signals through a NgR1-and p75/Troy-containing receptor complex, the G-protein-coupled receptor (GPCR) sphingosine 1-phosphate receptor 2 (S1PR2) was recently found as the signal-transducing receptor for Nogo-A-∆20 (Kempf et al., 2014) .
Since several ligand -receptor interactions are modulated by co-receptors or specific functional membrane scaffolds, we were interested in components that could exert such a modulation and fine-tuning of the Nogo-A-∆20-induced S1PR2-signaling. Based on the same yeast two-hybrid screen which revealed S1PR2 as Nogo-A-∆20 interaction partner, we identified the 4-transmembrane-spanning protein tetraspanin-3 (TSPAN3) as an additional interaction partner for Nogo-A-∆20. The tetraspanin-family comprises 33 mammalian celltype-specific members (Hemler, 2005) . In the central nervous system, TSPAN3 is expressed in neurons, oligodendrocytes and astrocytes (Tiwari-Woodruff et al., 2001; Tiwari-Woodruff et al., 2004) . In the immune and vascular system, tetraspanin proteins act as organizers of functional microdomains and multi-subunit receptor complexes (Charrin et al., 2014; Hemler, 2005; Junge et al., 2009; Levy and Shoham, 2005; Mattila et al., 2013) . Here we show that TSPAN3 acts as a signaling complex organizer and core element for the Nogo-A-Δ20 -S1PR2 G-protein-coupled receptor complex, ensuring neurite outgrowth and spreading
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inhibition. TSPAN3 is required for the initial contact of Nogo-A with the cell surface and its assembly into the S1PR2-containing signaling platforms: TSPAN3 facilitates Nogo-A-Δ20-induced S1PR2-clustering, and silenced TSPAN3 expression abolishes Nogo-A-induced RhoA activation. Potent Nogo-A-Δ20-induced neurite outgrowth and spreading restriction depends on the interaction with tetraspanins and the presence of spatiotemporally coordinated TSPAN3 microdomains. This reveals a high relevance of a tetraspanin co-receptor in a Nogo-A signal receptor complex inhibiting neurite outgrowth. These insights suggest similar modes of action of tetraspanins in other receptor complexes regulating cell adhesion, spreading and migration during development, in immune responses or in cancer.
Results

Tetraspanin-3 co-localizes with Nogo-A-Δ20, stabilizes its cell surface binding and accompanies Nogo-A during internalization into early endosomes
TSPAN3 was identified as an interaction partner of Nogo-A-Δ20 in a yeast two-hybrid screen conducted under very stringent conditions, which also led to the identification of S1PR2 as a signal-transducing receptor for Nogo-A-Δ20 (Kempf et al., 2014) . In order to validate the suggested interaction of Nogo-A-Δ20 and TSPAN3, we performed co-immunoprecipitation experiments using NIH 3T3 cells which endogenously express TSPAN3 as well as S1PR2
and strongly respond to Nogo-A-Δ20 by inhibition of cell spreading and anti-adhesive effects (Joset et al., 2010; Kempf et al., 2014; Oertle et al., 2003) . NIH 3T3 cells were incubated with hemagglutinin (HA)-tagged recombinant Nogo-A-Δ20. After lysis and immunoprecipitation with TSPAN3 specific antibodies, HA-Nogo-A-Δ20 could be found in the TSPAN3 immunoprecipitated fractions, but not in mouse IgG2b isotype control fractions (Fig. 1A) .
In the next step, we were interested in the interaction of TSPAN3 and Nogo-A-Δ20 at the cell surface. Cell surface staining of living NIH 3T3 fibroblasts incubated with Nogo-A-Δ20 at 4 °C showed co-localizations of TSPAN3 and Nogo-A-Δ20 in distinct clusters at the cell surface (Fig. 1B) . Knockdown of TSPAN3 (30 ± 8.8 % of control; Fig. 2C ) strongly reduced Nogo-A-Δ20 cell surface binding ( Fig. 1C and 1D ; for knockdown quantification see Fig.   2C ). TSPAN3 siRNA-treated cells bound significantly less Nogo-A-Δ20 at their surface (41.7 ± 2.7 clusters/ cell) compared to control siRNA-treated cells (81.6 ± 4.5 clusters/ cell, p<0.001; Fig. 1D ). In addition, the mean Nogo-A-Δ20 surface-bound cluster size was significantly smaller after TSPAN3 knockdown (2.6 ± 0.15 μm 2 vs. 3.2 ± 0.1 μm 2 in the control, p<0.001; Fig. 1D ).
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Thus, TSPAN3 is essential for Nogo-A-Δ20 cell surface binding at an early stage of contact of the ligand with the cell surface.
The fate of the Nogo-A-∆20 -TSPAN3 complex was followed and quantified at different incubation times of Nogo-A-∆20 (3 -40 min) at 37 °C; representative maximum projections of single cells are shown in Fig. 1E and Fig. S1A . The image stacks of single 3T3 cells revealed a strong co-localization of TSPAN3 and Nogo-A-∆20 at 3 min of incubation (68 ± 1.8 % Nogo-A-∆20 co-localized with TSPAN3, 90 ± 1.3 % TSPAN3 co-localized with Nogo-A-∆20; Fig. 1E and 1F ), especially at the cell periphery along the ruffling membranes. After 7-15 min, Nogo-A-∆20 was associated with and partially trans-located via wave-like ruffling membranes towards the dorsal cell surface, still co-localized with TSPAN3 ( Fig. 1E, 1F and (Fig. S1C ). TSPAN3 co-localized with Nogo-A-∆20 in these EEA1-positive early endosomes (Fig. 1G) . Upon 25 min, the trafficking of Nogo-A-∆20 and TSPAN3 started to separate, indicated by a decline of co-localization (57.1 ± 3.5 % Nogo-A-∆20 co-localized with TSPAN3, 64.9 ± 3.2 % TSPAN3 co-localized with Nogo-A-∆20; Fig.   1F and Fig. S1A ). An even lower co-localization at 40 min (27.6 ± 2.0 % Nogo-A-∆20 colocalized with TSPAN3, 31.6 ± 1.8 % TSPAN3 co-localized with Nogo-A-∆20; Fig. 1E and 1F) was consistent with a co-localization of TSPAN3 with Rab11-positive recycling endosomes and Nogo-A-∆20 enrichment in Lamp-1-positive lysosomal late endosomes (Fig.   1H ).
Tetraspanin-3 is functionally relevant for Nogo-A-∆20-induced inhibition of fibroblast spreading and neurite outgrowth
Since Nogo-A-∆20 inhibits neurite outgrowth and spreading of fibroblasts (Kempf et al., 2014; Oertle et al., 2003) , we investigated potential changes in Nogo-A-∆20-mediated functional effects in absence of TSPAN3. First, we tested the ability of fibroblasts to spread on Nogo-A-∆20 or on control substrate after stable lentiviral shRNA-mediated TSPAN3 knockdown. TSPAN3 knockdown ( Fig. 2A) S2 ).
In the next step, we investigated the Nogo-A-∆20-induced neurite outgrowth inhibition after TSPAN3 knockdown. The neurite outgrowth was reduced from 100 ± 3.94 % on a control substrate to 70.1 ± 2.76 % on Nogo-A-∆20 (25 pmol/ cm 2 ) in control siRNA transfected cortical neurons. In comparison, the knockdown of TSPAN3 led to 81.3 ± 3.3 % of mean neurite outgrowth length per cell in embryonic cortical neurons (p<0.01; Fig. 2H ). Taken together, these results show that TSPAN3 is relevant for Nogo-A-∆20-induced inhibition of fibroblast spreading and neurite outgrowth.
Nogo-A-Δ20 induces a dynamic reorganization of TSPAN3 at the nanoscale level in the cell membrane
Interactions of tetraspanins with their partner proteins were described to be spatially coordinated within nanoscale assemblies (Hemler, 2005) , without excluding interactions outside of these areas (Berditchevski and Rubinstein, 2013; Cornea and Conn, 2014; Espenel et al., 2008; Mattila et al., 2013 Fig. 3B ). Since we observed TSPAN3 to be localized in confined areas at the cell surface, we hypothesized that this increased mobility may be due to the Nogo-A-∆20 dependent release of TSPAN3 molecules from these areas, as also suggested by an increased surface coverage of the tracks (Fig. 3A) . To test this hypothesis quantitatively, we followed the motion of individual molecules of TSPAN3 via quantum dots (QDs) to detect dynamic changes in mobility of individual molecules after
Nogo-A-∆20 addition ( Fig nm diameter (blue in Fig. 3C ), B) freely diffusing molecules (red) and C) molecules that alternated between these two states (black). After 3-11 min of Nogo-A-∆20-addition, fewer molecules remained in the confined state (27 ± 2.4 %) than in untreated cells (52.4 ± 3.6 %, p<0.05, Fig. 3E ). In addition, in Nogo-A-∆20-treated cells we found significantly more single molecules that changed their pattern from confined to free motion, often repeatedly (44.1 ± 9.9 % vs. 8.3 ± 3.3 % in the control group, p<0.01, Fig. 3F ). Furthermore, TSPAN3 molecules
showed an increased interaction with each other upon Nogo-A-∆20-treatment (controlJournal of Cell Science Accepted manuscript treatment 23.5 ± 3.1 % vs. Nogo-A-∆20-treatment 33.4 ± 3.1 % of total tracks, p<0.05; Fig.   3G ). These results reveal that Nogo-A-∆20 binding increases the mobility of TSPAN3 molecules and induces a spatiotemporal reorganization of cell surface TSPAN3 at the nanoscale level.
Dynamic complex formation between TSPAN3 and the Nogo-A receptor S1PR2
An important question was whether the Nogo-A-Δ20-induced TSPAN3 reorganization is related to interactions with the Nogo-A-Δ20 signal-transducing receptor S1PR2. In absence of purified recombinant Nogo-A-Δ20, we observed a partial co-localization of TSPAN3 and S1PR2 at endogenous expression levels in Nogo-A-Δ20-responsive fibroblasts and neurons.
Patch-like cell surface co-localization of endogenous TSPAN3 and S1PR2 at peripheral regions of the cells were visualized by immunofluorescence in two different Nogo-A-Δ20-responsive cell types, non-neuronal NIH 3T3 fibroblasts and primary embryonic (E19) cortical neurons (after 4 days in vitro) (Fig. 4A ). Furthermore, S1PR2 was coimmunoprecipitated with TSPAN3 by TSPAN3-specific antibodies from 3T3 cell lysates ( Fig. 4B ). In the next step, HEK cells transfected with either TSPAN3-mycDDK alone, TSPAN7-mycDDK alone, S1PR2-GFP alone, or TSPAN3-mycDDK as well as S1PR2-GFP, or TSPAN7-mycDDK and S1PR2-GFP were treated with Nogo-A-∆20 and subsequently lysed with a mild detergent (Fig. 4C ). Co-immunoprecipitation with either anti-mycDDK (ms IgG; lane 2, 3, 5, 7, 8, 9) or isotype control (ms IgG) antibodies (lane 4 & 6) and a subsequent detection with anti-GFP revealed that S1PR2-GFP exclusively co-immunoprecipitated with TSPAN3-mycDDK, but not with TSPAN7-mycDDK or with a isotype control ms IgG antibody. Lysates 2 and 5 (overexpressing TSPAN3-mycDDK and S1PR2-GFP) correspond to lysates from two independent experiments. The association of S1PR2-GFP with TSPAN-3-mycDDK was further confirmed by mass spectrometry (data not shown), in a similar approach as used for the co-immunoprecipitation and detection on the PVDF-membrane.
Therefore, immunoprecipitation of mycDDK-TSPAN3 in S1PR2-GFP and TSPAN3
overexpressing HEK cells was subsequently followed after gel electrophoresis by mass spectrometry of a Coomassie-stained gel band at ~ 65 kDa (size of S1PR2-GFP).
On a qualitative level, immunofluorescence also indicated a partial co-localization in a tripartite complex of Nogo-A-Δ20, TSPAN3 and S1PR2 in distinct clusters in 3T3 cells incubated with Nogo-A-Δ20 for 15 min at 37 °C (Fig. 4D ).
To study if the presence of Nogo-A-Δ20 enhances complex formation of its receptor S1PR2
with TSPAN3, we used the proximity ligation assay (PLA) (Soderberg et al., 2006) , which enables in situ visualization and quantification of protein -protein interactions in a proximity of minimum 40 nm . TSPAN3/ S1PR2 interactions were quantified after 0, 10 and 25 min of Nogo-A-Δ20 incubation (Fig. 4G ). The amount of interactions of TSPAN3 and S1PR2 at 0 min of Nogo-A-∆20 incubation (5.2 ± 0.4 PLA-signals/ cell) increased significantly after 10 min (23.2 ± 3.3 PLA-signals/ cell, p<0.0001), followed by a decreased interaction after 25 min (13.3 ± 1.6 PLA-signals/ cell, p<0.001 compared to 10 min and p<0.05 compared to 0 min; Fig. 4G ). In contrast, no PLA-signals were obtained upon Nogo-A-∆20 incubation (for 0, 10, 25 min) in 3T3 cells transfected with TSPAN3 siRNA (n=50 cells per group) (Fig. S4A ). These observations point to a temporally regulated dynamic complex assembly of the signal-transducing Nogo-A-Δ20 receptor S1PR2 and the co-receptor TSPAN3 in presence of Nogo-A-∆20. The disassembly starts at the time of transition from early to late endocytosis, consistent with the previously described separation along different trafficking routes.
TSPAN3 is required for Nogo-A-Δ20-induced S1PR2 clustering and downstream signaling
Key re-arrangements of TSPAN3 in the plasma membrane at the nanoscale level and complex formation with S1PR2 at the microscale level occurred mostly during the first 10 min of Nogo-A-∆20-incubation. To study the role of TSPAN3 for the Nogo-A induced clustering of S1PR2 and the subsequent intracellular signaling events, the receptor clustering of S1PR2 at the cell surface was quantified in control siRNA or TSPAN3 siRNA transfected cells after control-or Nogo-A-∆20-treatment ( Fig. 5A and 5B). The size of the Nogo-A-∆20-induced S1PR2 cell surface clusters (1.067 ± 0.05177 μm 2 control-treated vs. 1.562 ± 0.08260 μm 2 in ∆20-treated, siRNA ctrl cells) was strongly decreased by knocking down TSPAN3 (0.9588 ± 0.03730 μm 2 ∆20-treated TSPAN3 siRNA, compared to ∆20-treated siRNA ctrl; p<0.0001;
Fig
. 5B, for knockdown quantification see Fig. 2C ). Comparing total S1PR2-cell surface levels, siRNA-mediated knock down of TSPAN3, compared to control siRNA transfection did not significantly change S1PR2 presence at the cell surface levels. However, significantly increased Nogo-A-∆20-induced total S1PR2 cell surface levels remained at baseline, upon siRNA-mediated knock down of TSPAN3, compared to control siRNA transfection (Fig.   S4B ). This suggests that TSPAN3 is not generally involved in the transport of S1PR2 to the cell surface, but potentially stabilizes a dynamic request of more S1PR2 at the cell surface in presence of Nogo-A-∆20.
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RhoA GTPase activation is a decisive Nogo-A-∆20-induced intracellular signaling step (Joset et al., 2010; Kempf et al., 2014) . The siRNA-mediated down-regulation of TSPAN3 resulted in 58.0 ± 6.3 % decreased Nogo-A-∆20-induced RhoA-activation compared to control siRNA Nogo-A-∆20-treated cells (p<0.01; Fig. 5C and 5D, for knockdown quantification see Fig.   2C ). All these results demonstrate that TSPAN3 is an important functional player for Nogo-A-Δ20-induced S1PR2 clustering and subsequent signal transduction leading to Nogo-A-∆20's inhibitory effects.
Finally, we investigated a potential additive effect of TSPAN3 and S1PR2 interference on fibroblast spreading inhibition by Nogo-A-∆20. The S1PR2-specific blocker JTE-013
(Marsolais and Rosen, 2009) was shown to significantly counteract Nogo-A-∆20-mediated cell spreading inhibition (Kempf et al., 2014) . We combined JTE-013-treatment with TSPAN3 siRNA-mediated knockdown in 3T3 cells plated on a Nogo-A-∆20 substrate (Fig.   5E ). Neither the single nor the combined treatments affected fibroblast spreading on the control plastic substrate. Combined JTE-013-treatment and TSPAN3 knockdown (72.6 ± 2.0 % spreading, compared to JTE-013 alone (66.2 ± 2.0 %) or TSPAN3 siRNA alone (69.3 ± 1.6 %), respectively, p>0.05; Fig. 5E ), did not reveal a significantly enhanced Nogo-A-∆20-anatgonism of the combined treatment. The absence of a strong additive effect of the combined S1PR2 and TSPAN3-blockage is in line with the findings that both proteins exist in the same receptor complex, mediating the Nogo-A-∆20-induced inhibition of cell spreading in a concerted manner.
Discussion
After addition of the Nogo-A active fragment Nogo-A-∆20 to Nogo-A responsive 3T3
fibroblasts, Nogo-A-∆20 co-localized with the membrane protein TSPAN3 on the cell surface.
Binding of Nogo-A-∆20 was strongly reduced after TSPAN3 siRNA-mediated knockdown.
Surface membrane TSPAN3 molecules co-localized with Nogo-A-∆20, which progressively associated with S1PR2. These multi-subunit complexes were subsequently internalized into early endosomes. Knockdown of TSPAN3 reduced activation of the Nogo-A signal transducer RhoA and the inhibitory effects of Nogo-A-∆20 on cell spreading and neurite outgrowth, showing that the tetraspanin TSPAN3 organizes, as a co-receptor, a signaling platform for Nogo-A-∆20/ S1PR2-mediated inhibition of neurite outgrowth and cell spreading. Ligand -receptor interactions of e.g. neurotrophic factors or Nogo-A at the plasma membrane are followed by the internalization of the assembled complex and formation of signaling endosomes (Joset et al., 2010; Zweifel et al., 2005) . Nogo-A-∆20 internalization has been shown to be an indispensable step for RhoA activation and growth cone collapse (Joset et al., 2010) . Co-internalization of Nogo-A and S1PR2 into early endosomes is detectable after 15 min of incubation (Kempf et al., 2014) .
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On the surface membrane, co-localization of TSPAN3 and Nogo-A-∆20 was detectable at
Journal of Cell Science Accepted manuscript time points preceding internalization, first at ruffling membranes in the cell periphery and subsequently at dorsal circular macropinocytic ruffles. These structures have been shown before to be induced and required for internalization of ligands like epidermal growth factor (EGF), the neurotrophin NGF, or for the re-distribution of intergins (Gu et al., 2011; Hoon et al., 2012; Valdez et al., 2007; Zweifel et al., 2005) . TSPAN3 and Nogo-A-∆20 were first coassociated with local actin rings (7-15 min), which typically accompany macropinocytic events (Fournier et al., 2000; Kaksonen et al., 2000) . At later time points (15-25 min), we observed TSPAN3 and Nogo-A-∆20 in EEA1-positive early endosomes. Interestingly, the internalized complex of TSPAN3 and Nogo-A-∆20 disassembled at later time points (40 min) during differential late trafficking. These results provide compelling evidence that TSPAN3
accompanies Nogo-A-∆20 along its multistep route from cell surface binding to fusion with early endosomes. This spatiotemporally coordinated relationship between the peptide ligand and the tetraspanin co-receptor comprises reorganizations and translocations at the nano-and microscale level, accompanied by an increased association with the signal-transducing GPCR.
Tetraspanin-3 enables Nogo-A-∆20-induced G-protein-coupled signaling via S1PR2
In cells of the immune and vascular system, tetraspanin-enriched microdomains often serve as 
Nogo-A multi-subunit signaling complexes
Our results extend and refine the emerging concept that repulsive and attractive guidance cues and a diversity of other ligands signal through receptor complexes consisting of several partners (Chao, 2003; Giger et al., 2008; Neufeld and Kessler, 2008; Niehrs, 2012) 
Material & Methods
Yeast two-hybrid system
The identification of Nogo-A-∆20 interaction partner TSPAN3 was based on the same yeast two-hybrid screen as described before for the identification of the signal-transducing receptor S1PR2 (Kempf et al., 2014 ). Recent studies demonstrate that a classical Y2H approach is well suited to screen for TSPAN protein interactions. Thus, TSPANs have been used as a Y2H
prey (Bhave et al., 2013; Chen and Enns, 2015; Liu et al., 2009 ) as well as a bait (TiwariWoodruff et al., 2001 ). In our screen, the number of different baits per prey was divided by the total number of times this prey was isolated in our screens. This normalization step accounts for the abundance of the prey in the cDNA libraries screened; for details on our method please see: (Koegl and Uetz, 2007; Mohr and Koegl, 2012) . All our hits were observed multiple times under high stringency conditions. It has also been observed that libraries that express protein fragments have a greater chance of containing prey fragments that lack "difficult" protein regions, such as transmembrane domains. Consequently, they may Journal of Cell Science Accepted manuscript detect interactions that are lost when using arrays of full-length proteins. Importantly, the NogoA-∆20 -TSPAN3 interaction observed by Y2Hd has been verified by us with several independent methods.
Cell culture
3T3 Swiss and NIH fibroblasts (ATCC) were cultivated in DMEM (Invitrogen, 61965-026) supplemented with 10 % newborn calf serum (Invitrogen). Embryonic day (E) 19 rat cortical neurons were prepared as described previously (Lee et al., 2008) and cultivated in Neurobasal medium (Invitrogen, 21103-049) containing B27 supplement, 25 mM glucose, 1 mM glutamine, 50 U/ ml penicillin 50 μg/ ml streptomycin. HEK293T cells (ATCC) were maintained in DMEM containing 10% fetal calf serum (Invitrogen, 21885-025).
Co-Immunoprecipitation assays
Co-immunoprecipitation was performed with lysates of 3T3 fibroblasts, incubated with HA- μg/ 500 μl protein lysate) or isotype control mouse IgG2b antibodies (Life Technologies, MG2B00) at 4 °C overnight. The next day a pre-clearing step was performed: 50 μl of preblocked ProteinG beads (Pierce; in 1% BSA in lysis buffer) were added to the samples for 30 min on a rocking wheel at 4 °C. After centrifugation, the samples were incubated with ProteinG beads (50 μl/ 500 μl lysate) for 2 h on a rocking wheel at 4 °C. Beads were washed three times, and bound proteins were eluted and prepared for SDS-PAGE and transferred onto a PVDF membrane. Overnight incubation at 4°C was performed with either rat anti-HA (Roche, 11867423001, 0.5 μg/ ml) or human IgG F(ab')2 fragment anti-S1PR2 (AbD Serotec custom made HuCAL antibody AbD14533.1 addressing extracellular S1PR2 ECL2, 1.86 μg/ ml). The following HRP-secondary antibodies were used: goat anti-rat HRP-conjugate (Thermo Scientific, PA1-28779, 0.1 μg/ ml) or goat anti-human IgG Fab-specific HRPconjugate (AbD Serotec, PA1-28779, 1 μg/ ml).
Co-immunoprecipitation with the tagged S1PR2, TSPAN3 or TSPAN7 was performed with HEK293T cells. Cells cultivated in 10-cm dishes were transiently transfected with
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Lipofectamine 3000 transfection reagent (Life Technologies, L3000-008) and 2.5 µg TrueORF cDNA plasmids (TSPAN3-mycDDK or TSAPN7-mycDDK) (OriGene MR203238
and OriGene MR203045) and/or S1PR2-GFP plasmid (cloned by Michael Arzt, Brain
Research Institute Zurich). Fourty-eight hours after-transfection, cells were treated with 500 nM Nogo-A-∆20 for 10 min at 37 °C and used for co-immunoprecipitation. Briefly, cells In vitro bioassays: fibroblast spreading and neurite outgrowth 3T3 fibroblast spreading assay was performed as described previously (Kempf et al., 2014; Oertle et al., 2003) . Four-well plates (Greiner) were coated with indicated Nogo-A-∆20
concentrations at 4 °C overnight. Transient knockdown was performed using TSPAN3 ON-TARGET plus siRNA SMARTpool Dharmacon (Thermo Scientific). A total of 3x10 4 Swiss 3T3 were transfected with 50 nM siRNA using the DharmaFECT 3 transfection reagent in serum-free DMEM medium (Gibco) 24 h after plating. Transfection efficiency was determined by transfecting a fluorescently tagged non-targeting siGLO-red RISC-free siRNA.
Cells transfected with the siCONTROL non-targenting siRNA pool was used as negative according to the manufacturer's instructions) as described before (Kempf et al., 2014) .
The neurite outgrowth assay with E19 rat cortical neurons was performed as described previously (Kempf et al., 2014; Lee et al., 2008) . The transient knockdown was achieved as described above for the 3T3 fibroblasts, using TSPAN3 ON-TARGET plus siRNA SMARTpool Dharmacon (rat-specific; Thermo Scientific). In outgrowth experiments, the four-well plates were pre-coated with 0.3 mg/ ml Poly-L-Lysine (PLL; Sigma-Aldrich) for 1 h at 37 °C, before coating with the different substrates. For the neurite outgrowth, the cells were cultured for 24 h at 37 °C and 5% CO2, then fixed with 4% PFA and stained with anti-βIII tubulin. The mean neurite length is referred to as the mean total length of all neurites per cell (Kempf et al., 2014) . Each experiment was performed at least three times in four replicate wells. Statistical analysis was performed in GraphPad Prism5 using a one-way ANOVA test followed by a Bonferroni post hoc test or by using an unpaired Student's t-test.
qRT-PCR
Seventy-two hours post-transfection, total mRNA was isolated from siRNA transfected cells 
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Immuncytochemistry 3T3 cells and rat E19 cortical neurons (DIV4) were fixed with 4 % PFA for 15 min, washed, permeabilized with 0.1 % Triton X-100 and blocked with 2 % goat serum or 2 % fish skin gelatin. For primary antibody incubation the following antibodies were used: anti-S1PR2
(AbD Serotec, 2.8 μg/ ml), anti-TSPAN3 (Ptglab, 3.3 μg/ ml), anti-HA (Roche, 0.4 μg/ ml), rabbit anti-EEA1 (Cell signaling, 3.3 μg/ ml, rat anti-Lamp-1 (Becton Dickinson, 5 μg/ ml).
The following secondary antibodies were used: Alexa488-conjugated goat anti-mouse IgG (Invitrogen; 1 μg/ ml), Cy3-conjugated goat anti-rabbit IgG (Invitrogen, 1 μg/ ml), Alexa488-conjugated goat anti-rat IgG (Invitrogen, 1 μg/ ml), Biotin SP-conjugated AffiniPure goat anti-human IgG F(ab')2 fragment specific (Jackson ImmunoResearch Laboratories, 2 μg/ ml), all confocal slices either of single channels, both channels or xz and yz side views of both channels. Data analysis was performed by GraphPad Prism5 performing statistical analysis using a one-way ANOVA test followed by a Bonferroni post hoc test. Data were given as the mean value ± SEM.
Recombinant fusion protein production
Recombinant protein Nogo-A-∆20 (rat aa544-725) was purified as described previously (Joset et al., 2010) , (Kempf et al., 2014) . Briefly, BL21/DE3 Escherichia coli were transformed with the pET28 a+ expression vector (Novagen) containing His-/T7-or His-/HA-tagged Nogo-A ∆20 and cultured at 37 °C to reach an OD600 of 0.6-1 AU. Protein expression was induced by addition of 1 mM IPTG for 2 h at 30 °C. Fusion proteins were purified using HiTrap TALON crude column (GE Healthcare) and the batch-specific inhibitory concentration 50 (IC50-value) was determined with a fibroblast spreading assay on increasing Nogo-A-∆20
concentrations.
RhoA Immunocytochemistry
siRNA control treated and siRNA TSPAN3 treated 3T3 cells were plated for 2 h and treated for 20 min with 1 μM Nogo-A-∆20-T7. Cells were fixed, permeabilized, blocked and stained with an anti-RhoA-GTP antibody (NewEast Biosciences, 2.5 μg/ ml), detected with an Alexa488-conjugated goat anti-mouse antibody (1 μg/ ml) and co-stained with Alexa Fluor® 594 phalloidin. A total of 135 cells from 3 independent experiments were imaged per group and automatized quantification of mean intensity RhoA-GTP levels per cell was performed with ImageJ (NIH).
In situ proximity ligation assay (PLA)
Proximity ligation assay detection of S1PR2 / TSPAN3 interaction was performed as previously described (Soderberg et al., 2006) using in situ PLA Duolink Detection kit orange (Olink Bioscience) according to the manufacturer's instructions for Duolink labeling, blocking and detection protocol. PLA Probe anti-mouse PLUS reagent (Olink) was used to label directly the primary mouse anti-TSPAN3 antibody and PLA Probe anti-goat MINUS reagent (Olink) was used to label the secondary goat anti-human F(ab')2 antibody. Briefly,
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3T3 fibroblasts were incubated with 500 nM Nogo-A-∆20-T7 for different incubation times (0, 10, 25 min). Cells were fixed with 2 % PFA for 15 min, washed, permeabilized with 0.1 % Triton X-100 and blocked with 2 % goat serum or 2 % fish skin gelatin for 30 min and additionally with Duolink blocking solution for further 30 min at 37 °C. Subsequently, cells were incubated with primary antibodies (PLUS-labeled mouse anti-TSPAN3, 4 μg/ ml and human F(ab')2 fragment anti-S1PR2, 4 μg/ ml) in PLA probe diluent for 1 h at 37 °C. 
Single-molecule-imaging and particle tracking
Anti-TSPAN3 antibodies were covalently labeled with Atto647N (Atto-Tec) according to the manufacturer's instructions and as described before for nanobody-labeling (Ries et al., 2012) .
Briefly, the anti-TSPAN3 antibody was dialyzed into 0.2 M NaHCO3, pH 8.2 in a minidialysis unit (Thermo Scientific). The amine-reactive fluorophore (N-hydroxysuccinimidyl (NHS) -ester) Atto647N was dissolved in DMSO (10 mg/ ml) and added to fivefold molar excess to the antibodies. The labeling reaction was performed for 1 h at room temperature and excess dye was removed via buffer exchange into 1x PBS with a Zeba Spin desalting column (Thermo Scientific). 3T3 fibroblasts were treated with 500 nM Nogo-A-∆20-T7 or equal volumes of 1x PBS for a maximum of 27 min. Cells were grown in DMEM without phenol red to reduce background fluorescence (Gibco, 11880-028) . Live-cell single moleculetracking was performed with a custom-built microscope, as described before (Ries et al., 2012) . The temperature was stabilized at 37 °C and image acquisition started at 2 min before (baseline) and during treatment in blocks à 5000 frames (25 ms exposure time per frame).
Localization analysis was performed as described previously (Schoen et al., 2011) .
Coordinates of single-molecules were determined for each frame and linked in consecutive frames to obtain trajectories. The mean square displacement (MSD) was plotted versus time
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and the diffusion coefficient D determined by linearly fitting the points 2 to 4 (MSD = 4Dt).
For mean D values, tracks > 32 frames were considered.
Quantum dot (Qdot) imaging was conducted with Qdot® 655 Goat F(ab')2 Anti-Mouse IgG conjugates (1 μM stock solution, Life Technologies) and Qdots were prepared similarly as described before (Saint-Michel et al., 2009) . Briefly, Qdots were mixed with anti-TSPAN3
antibodies (1 mg/ ml, Ptglab) in 1x PBS for 20 min at a 3:1 dilution, blocked with 10 % casein solution and centrifuged at 5000 x g for 3 min prior to use. Qdot -anti-TSPAN3 complexes (2 μg/ ml in DMEM without phenol red, Gibco, 11880-028) were visualized using 
